EQUILATERAL ENT share price
NSE: EQUILATERAAutoLuxury Goods
EQUILATERAL ENT at a glance
With a market capitalisation of ₹25 Cr, it ranks 3482nd by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Auto sector; its industry is Luxury Goods.
Its return on equity was 1.6% in FY25. In Q4 FY26, the quarter ended 31 Mar 2026, revenue was ₹8 Cr (+49.3% year on year) and net profit −₹0 Cr (−225.0%), on a standalone basis. Promoters held 8.04% of the company as of 30 Jun 2026.
Key numbers
- Market cap
- ₹25 CrRank 3482 on NSE
- Price to book
- 3.58×FY25
- EPS (TTM)
- ₹0.19to Q4 FY26
- ROE
- 1.6%FY25
- ROCE
- 1.6%FY25
- Debt to equity
- 0.07FY25
- Net profit margin
- 1.2%FY25
- Book value / share
- ₹8.97FY25
Returns to 22 Oct 2026
| Period | 1 day | 1 week | 1 month | 3 months | 1 year |
|---|---|---|---|---|---|
| Price change | — | — | — | — | — |
EQUILATERAL ENT quarterly results
| Quarter | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹1 Cr | ₹1 Cr | ₹7 Cr | ₹5 Cr | ₹16 Cr | ₹25 Cr | ₹10 Cr | ₹8 Cr |
| Revenue YoY | — | +106.8% | +166.1% | −34.2% | +1,127.8% | +1,920.5% | +31.9% | +49.3% |
| Net profit | −₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | −₹0 Cr |
| Net profit YoY | — | −75.0% | — | +33.3% | — | +400.0% | −80.0% | −225.0% |
| Net margin | −6.0% | 2.5% | 2.1% | 1.5% | 1.0% | 0.6% | 0.3% | −1.3% |
| EPS | −₹0.06 | ₹0.02 | ₹0.12 | ₹0.07 | ₹0.13 | ₹0.12 | ₹0.02 | −₹0.08 |
EQUILATERAL ENT financials
| Item | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|
| Revenue | ₹2 Cr | ₹0 Cr | ₹6 Cr | ₹2 Cr | ₹11 Cr | ₹15 Cr |
| Operating profit | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Net profit | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| EPS (₹) | ₹0.00 | ₹0.00 | ₹0.01 | ₹0.02 | ₹0.02 | ₹0.15 |
| Cash from operations | −₹0 Cr | −₹1 Cr | ₹6 Cr | ₹6 Cr | ₹0 Cr | ₹7 Cr |
| Total debt | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹1 Cr |
| Shareholders' equity | ₹11 Cr | ₹11 Cr | ₹11 Cr | ₹11 Cr | ₹11 Cr | ₹11 Cr |
EQUILATERAL ENT shareholding pattern
| Holder | 31 Mar 2025 | 30 Jun 2025 | 30 Sep 2025 | 31 Dec 2025 | 31 Mar 2026 | 30 Jun 2026 |
|---|---|---|---|---|---|---|
| Promoters | 8.04% | 8.04% | 8.04% | 8.04% | 8.04% | 8.04% |
| Non-institutions | 91.96% | 91.96% | 91.96% | 91.96% | 91.96% | 91.96% |
EQUILATERAL ENT vs peers
The listed Auto companies nearest to EQUILATERAL ENT by market capitalisation.
| Company | Price | 1 day | 1 year | Market cap | P/E | ROE |
|---|---|---|---|---|---|---|
| VICTORYEVVictory Electri | ₹12.40 | −4.98% | — | ₹30 Cr | — | — |
| TIRUPATIINTIRUPATI INNO | — | — | — | ₹27 Cr | — | — |
| STANDRDBATStandard Batter | — | — | — | ₹26 Cr | — | — |
| EQUILATERAEQUILATERAL ENT | — | — | — | ₹25 Cr | — | — |
| AMSAMS POLYMERS | — | — | — | ₹16 Cr | — | — |
| CONTAINEContaine Tech | — | — | — | ₹15 Cr | — | — |
| KALYANIKalyani Commercials | ₹144.99 | +5.00% | — | ₹14 Cr | 6.2 | — |
Ask anything about EQUILATERAL ENT
Pivot answers on the live chart with evidence you can check, and tests strategies against EQUILATERA's own history. Try: “Why has EQUILATERA moved over the last three months?” · “Backtest a 50-day moving-average crossover on EQUILATERA over five years” · “Compare EQUILATERA with VICTORYEV on margins and valuation”
Frequently asked questions about EQUILATERAL ENT
What is the market cap of EQUILATERAL ENT?
EQUILATERAL ENT's market capitalisation is ₹25 Cr (₹25 Cr) at the 22 Oct 2026 close, ranking 3482nd among the NSE companies Pivot tracks.
What is the ROE and ROCE of EQUILATERAL ENT?
Return on equity was 1.6% in FY25 and return on capital employed was 1.6% in FY25 (standalone figures).
Is EQUILATERAL ENT a debt-free company?
No. EQUILATERAL ENT's debt-to-equity ratio was 0.07 in FY25, with total debt of ₹1 Cr.
What were EQUILATERAL ENT's latest quarterly results?
For Q4 FY26 (quarter ended 31 Mar 2026), EQUILATERAL ENT reported revenue of ₹8 Cr, +49.3% year on year, and net profit of −₹0 Cr, −225.0% year on year.
What is the shareholding pattern of EQUILATERAL ENT?
As of 30 Jun 2026: promoters 8.04%, non-institutions 91.96%.
Who are EQUILATERAL ENT's competitors?
The listed Auto companies closest to EQUILATERAL ENT by market cap are Victory Electri, TIRUPATI INNO, Standard Batter, AMS POLYMERS, Containe Tech and Kalyani Commercials.
Is EQUILATERAL ENT a good stock to buy?
Pivot does not give buy or sell recommendations. This page sets out EQUILATERAL ENT's price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on EQUILATERA against its own history before risking money. This is analysis, not financial advice.
Sources and method
Prices: NSE daily closes to 22 Oct 2026 (returns and ratios at the 22 Oct 2026 close). Fundamentals: company filings via Moneycontrol, standalone where available. Shareholding: exchange shareholding-pattern filings. The 52-week range uses intraday highs and lows; the chart marks closing prices. P/E is the last close over trailing twelve-month EPS. Market-cap rank is among the 4,183 NSE companies Pivot tracks; SEBI's bands call the top 100 large-cap and the next 150 mid-cap. Figures marked “—” are not available rather than zero. This is analysis, not financial advice.
More: all Auto stocks · companies starting with E · all NSE stocks · this page as text